Scotts Miracle Gro Pulls Hawthorne Guidance, Citing Uncertain Environment In Cannabis Industry, Stock Fallsbenzinga.comScotts Miracle-Gro Q2 results show margin gains and EBITDA growth despite sales decline; 2025 guidance maintained for US consumer segment.
The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbookbenzinga.comCannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B.
Scotts Miracle-Gro Q1 Earnings Beat Estimates Amid Stronger Consumer Engagement And Fall Salesbenzinga.comScotts Miracle-Gro Q1 earnings beat estimates with narrower losses, strong consumer engagement, and robust fall sales.
